Citizens Jmp Forecasts Strong Price Appreciation for Sabra Healthcare REIT (NASDAQ:SBRA) Stock

Sabra Healthcare REIT (NASDAQ:SBRA) had its price target increased by stock analysts at Citizens Jmp from $22.00 to $23.00 in a report issued on Wednesday,Benzinga reports. The firm currently has a “market outperform” rating on the real estate investment trust’s stock. Citizens Jmp’s price objective suggests a potential upside of 11.80% from the company’s previous close.

Several other brokerages have also issued reports on SBRA. Wells Fargo & Company increased their target price on Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock an “overweight” rating in a research report on Tuesday, November 25th. Wall Street Zen downgraded Sabra Healthcare REIT from a “hold” rating to a “sell” rating in a report on Friday, January 23rd. Jefferies Financial Group reissued a “buy” rating and set a $22.00 price objective on shares of Sabra Healthcare REIT in a research report on Monday, December 15th. Cantor Fitzgerald upped their target price on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock a “neutral” rating in a research report on Tuesday. Finally, UBS Group initiated coverage on shares of Sabra Healthcare REIT in a research report on Tuesday, November 18th. They set a “neutral” rating and a $20.00 price target for the company. Five equities research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $21.33.

Sabra Healthcare REIT Trading Down 0.1%

Sabra Healthcare REIT stock traded down $0.02 during trading hours on Wednesday, reaching $20.57. The stock had a trading volume of 99,395 shares, compared to its average volume of 2,814,905. The company has a fifty day simple moving average of $19.08 and a 200-day simple moving average of $18.80. Sabra Healthcare REIT has a 52 week low of $15.60 and a 52 week high of $20.70. The stock has a market cap of $5.13 billion, a PE ratio of 32.17, a PEG ratio of 1.42 and a beta of 0.67. The company has a debt-to-equity ratio of 0.90, a current ratio of 4.29 and a quick ratio of 4.29.

Sabra Healthcare REIT (NASDAQ:SBRA) last posted its earnings results on Thursday, February 12th. The real estate investment trust reported $0.11 earnings per share for the quarter, missing analysts’ consensus estimates of $0.37 by ($0.26). Sabra Healthcare REIT had a return on equity of 5.63% and a net margin of 20.09%.The firm had revenue of $201.35 million for the quarter, compared to analysts’ expectations of $201.97 million. During the same quarter in the prior year, the company posted $0.36 earnings per share. The business’s revenue for the quarter was up 16.2% on a year-over-year basis. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. Analysts forecast that Sabra Healthcare REIT will post 1.45 EPS for the current fiscal year.

Hedge Funds Weigh In On Sabra Healthcare REIT

A number of institutional investors and hedge funds have recently made changes to their positions in SBRA. Balyasny Asset Management L.P. boosted its stake in shares of Sabra Healthcare REIT by 753.7% during the 4th quarter. Balyasny Asset Management L.P. now owns 1,916,255 shares of the real estate investment trust’s stock worth $36,294,000 after acquiring an additional 1,691,792 shares during the last quarter. Boothbay Fund Management LLC raised its stake in shares of Sabra Healthcare REIT by 7.9% in the fourth quarter. Boothbay Fund Management LLC now owns 21,875 shares of the real estate investment trust’s stock worth $414,000 after buying an additional 1,609 shares during the period. Bridgeway Capital Management LLC lifted its position in shares of Sabra Healthcare REIT by 25.8% during the 4th quarter. Bridgeway Capital Management LLC now owns 106,800 shares of the real estate investment trust’s stock valued at $2,023,000 after buying an additional 21,900 shares in the last quarter. Freestone Grove Partners LP bought a new position in shares of Sabra Healthcare REIT during the 4th quarter valued at approximately $34,862,000. Finally, Guggenheim Capital LLC increased its holdings in Sabra Healthcare REIT by 48.4% in the 4th quarter. Guggenheim Capital LLC now owns 59,535 shares of the real estate investment trust’s stock worth $1,128,000 after acquiring an additional 19,424 shares in the last quarter. Hedge funds and other institutional investors own 99.40% of the company’s stock.

Sabra Healthcare REIT Company Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.